Mariotti, J.; Ricci, F.; Giordano, L.; Taurino, D.; Sarina, B.; De Philippis, C.; Mannina, D.; Carlo-Stella, C.; Bramanti, S.; Santoro, A.
Outcome of High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma after Different Numbers of Salvage Regimens. Cells 2024, 13, 118.
https://doi.org/10.3390/cells13020118
AMA Style
Mariotti J, Ricci F, Giordano L, Taurino D, Sarina B, De Philippis C, Mannina D, Carlo-Stella C, Bramanti S, Santoro A.
Outcome of High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma after Different Numbers of Salvage Regimens. Cells. 2024; 13(2):118.
https://doi.org/10.3390/cells13020118
Chicago/Turabian Style
Mariotti, Jacopo, Francesca Ricci, Laura Giordano, Daniela Taurino, Barbara Sarina, Chiara De Philippis, Daniele Mannina, Carmelo Carlo-Stella, Stefania Bramanti, and Armando Santoro.
2024. "Outcome of High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma after Different Numbers of Salvage Regimens" Cells 13, no. 2: 118.
https://doi.org/10.3390/cells13020118
APA Style
Mariotti, J., Ricci, F., Giordano, L., Taurino, D., Sarina, B., De Philippis, C., Mannina, D., Carlo-Stella, C., Bramanti, S., & Santoro, A.
(2024). Outcome of High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma after Different Numbers of Salvage Regimens. Cells, 13(2), 118.
https://doi.org/10.3390/cells13020118
